Summary of Significant Accounting Policies (Details) - Schedule of finite-lived and indefinite-lived intangible assets - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Cost	$ 15,518,000
Accumulated Amortization	(1,686,211)	$ (1,371,424)
Effect of Foreign Exchange Rates	(1,830,755)	383,633
Net Balance	12,001,036	14,530,209
Trademarks and tradenames [Member] | Curetis N.V [Member]
Finite-Lived Intangible Assets [Line Items]
Cost	1,768,000
Accumulated Amortization	(389,676)	(316,930)
Effect of Foreign Exchange Rates	(209,308)	43,015
Net Balance	1,169,016	1,494,085
Distributor relationships [Member] | Curetis N.V [Member]
Finite-Lived Intangible Assets [Line Items]
Cost	2,362,000
Accumulated Amortization	(347,069)	(282,277)
Effect of Foreign Exchange Rates	(279,628)	57,465
Net Balance	1,735,303	2,137,188
A50 - Developed technology [Member] | Curetis N.V [Member]
Finite-Lived Intangible Assets [Line Items]
Cost	349,000
Accumulated Amortization	(109,899)	(89,384)
Effect of Foreign Exchange Rates	(41,317)	8,492
Net Balance	197,784	268,108
Ares - Developed technology [Member] | Ares Genetics [Member]
Finite-Lived Intangible Assets [Line Items]
Cost	5,333,000
Accumulated Amortization	(839,567)	(682,833)
Effect of Foreign Exchange Rates	(631,354)	129,745
Net Balance	3,862,079	4,779,912
A30 – Acquired in-process research & development [Member] | Curetis N.V [Member]
Finite-Lived Intangible Assets [Line Items]
Cost	5,706,000
Accumulated Amortization
Effect of Foreign Exchange Rates	(669,146)	144,916
Net Balance	$ 5,036,854	$ 5,850,916